| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |